Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Listen to expert discussions and interviews in pharma and biopharma.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Urhekar joined Avalere Health in 2023 as Chief Operations Officer.
December 12, 2024
By: Charlie Sternberg
Associate Editor, Contract Pharma
Global strategic partner in healthcare, Avalere Health, has appointed Amar Urhekar as its new Chief Executive Officer (CEO). Urhekar joined Avalere Health in 2023 as Chief Operations Officer (COO) to unify the organization and build a global interdisciplinary offering across the product lifecycle. Now, 18 months later, he will be responsible for the overall leadership of Avalere Health. “Clients need partners who can navigate the complex confluence of stakeholders—from healthcare providers to payers, policymakers, and patients,” said Urhekar. “They need a strategic partner that can be at the center of their business and understand the evolving challenges. From driving decisions on investing in healthcare assets to policy influences and market access needs, medical communications and marketing brand launches, we have the exceptional talent with the wisdom and experience to guide, create, and implement successful solutions.” Urhekar brings a wealth of experience successfully driving transformative initiatives, including mergers and acquisitions, reinventing local and global organizations across IPG, Ashfield Health, and most recently, Inizio Evoke. His global career spanning multiple countries, driving business growth, and building purpose-led high-performing teams, makes him suitable to lead Avalere Health in its next phase of evolution. Urhekar replaces former CEO, Jon Koch, as part of a planned succession. Urhekar will continue to build on the strong foundation built by Koch over the last three and half years. Koch will be a strategic advisor to our Board until the end of March 2025. “Avalere Health is ready to achieve its true potential,” said Urhekar. “I look forward to partnering with our teams to further create an inspiring company that will amplify the patient voice like never before.”
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !